EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic and Laboratory Biomarkers in Early-Onset Versus Late-Onset Colorectal Cancer: A Case–Control Study

Mohamed H Eldesouki iD, Ahmed E Salem iD, Youssef Hafez iD, Ezz ElDien A Ibrahim iD, Mohammed Y Youssef iD, Fatima Khan, Mohammed Alomari, Sherif E ElHananfi, Aasma Shaukat

Cancers · 03.07.2026 · 18 (13) · 2152

DOI: 10.3390/cancers18132152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 03.07.2026. Verfasst von Mohamed H Eldesouki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, New York Medical College at Saint Michael's Medical Center, Newark, NJ 07102, USA. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The incidence of early-onset colorectal cancer (EOCRC) is rising, yet the relative contribution of metabolic, inflammatory, and laboratory abnormalities remains incompletely defined.

Objectives

We compared these associations between EOCRC and late-onset colorectal cancer (LOCRC) while addressing the possibility that some laboratory abnormalities may reflect occult cancer rather than antecedent risk.

Methods

We conducted a matched case–control study using the TriNetX US Network. Adults diagnosed with CRC between 2010 and 2023 were identified as EOCRC (18–49 years) or LOCRC (50–75 years). Patients with prior malignancy, inflammatory bowel disease, hereditary or familial CRC risk, or prior colectomy were excluded. Three separate analyses were performed. First, a direct EOCRC-versus-LOCRC comparison evaluated gastrointestinal symptoms during the 6 months preceding diagnosis. Second, EOCRC and LOCRC were each compared with their respective matched cancer-free controls to assess clinical, metabolic, and laboratory features during the 24 months preceding diagnosis. When multiple laboratory values were available, the most recent value preceding the index date was used. Conditional logistic regression estimated adjusted odds ratios with 95% confidence intervals, with Bonferroni correction applied for multiple comparisons.

Results

The direct matched EOCRC-versus-LOCRC comparison included 7752 patients with CRC, comprising 2584 with EOCRC and 5168 with LOCRC. EOCRC more frequently presented with rectal bleeding, abdominal pain, diarrhea, iron-deficiency anemia, and weight loss. Rectal tumors were more common in EOCRC, whereas proximal tumors were more common in LOCRC. In separate control-based analyses, 3217 patients with EOCRC and 12,112 patients with LOCRC were compared with 6434 and 24,336 matched cancer-free controls, respectively. The strongest independent features associated with EOCRC were severe obesity (aOR 2.61), microcytosis (aOR 2.29), low ferritin (aOR 2.11), and elevated C-reactive protein (aOR 1.87). Similar but generally attenuated associations were observed in LOCRC. In adjusted EOCRC-versus-LOCRC analyses, obesity (aOR 1.38), metabolic syndrome (aOR 1.41), and MASH (aOR 1.22) remained more closely associated with EOCRC.

Conclusions

EOCRC is associated with a distinct clinical–metabolic phenotype, with more pronounced metabolic, inflammatory, and hematologic abnormalities than LOCRC. These findings should be interpreted as hypothesis-generating prediagnostic associations, not as validated predictors or causal risk factors.

Schlagwörter

Stichwörter der Autor:innen

MASLDcolorectal cancerearly-onset colorectal cancerlate-onset colorectal cancermetabolic syndromeobesity

Autor:innen und Institutionen

  • Department of Internal Medicine, New York Medical College at Saint Michael's Medical Center, Newark, NJ 07102, USA.
  • Division of Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, FL 33331, USA.
  • Division of Gastroenterology and Hepatology, School of Medicine, St. Louis University, Saint Louis, MO 63104, USA.
  • Department of Internal Medicine, University of Missouri-Columbia, Columbia, MO 65212, USA.
  • Department of Internal Medicine, Hunt Regional Medical Center, Greenville, TX 75401, USA.
  • Department of Internal Medicine, Maimonides Medical Center, State University New York Downstate, Brooklyn, NY 11219, USA.

ORCID-Profile: Mohamed H Eldesouki, Ahmed E Salem, Youssef Hafez, Ezz ElDien A Ibrahim, Mohammed Y Youssef

Zitieren

APA

Eldesouki, M. H., Salem, A. E., Hafez, Y., Ibrahim, E. E. A., Youssef, M. Y., Khan, F., Alomari, M., ElHananfi, S. E., & Shaukat, A. (2026). Metabolic and Laboratory Biomarkers in Early-Onset Versus Late-Onset Colorectal Cancer: A Case–Control Study. Cancers, 18(13), 2152. https://doi.org/10.3390/cancers18132152

Vancouver

Eldesouki MH, Salem AE, Hafez Y, Ibrahim EEA, Youssef MY, Khan F, et al. Metabolic and Laboratory Biomarkers in Early-Onset Versus Late-Onset Colorectal Cancer: A Case–Control Study. Cancers. 2026;18(13):2152. doi:10.3390/cancers18132152

BibTeX
@article{Eldesouki2026,
  author = {Eldesouki, Mohamed H and Salem, Ahmed E and Hafez, Youssef and Ibrahim, Ezz ElDien A and Youssef, Mohammed Y and Khan, Fatima and Alomari, Mohammed and ElHananfi, Sherif E and Shaukat, Aasma},
  title = {Metabolic and Laboratory Biomarkers in Early-Onset Versus Late-Onset Colorectal Cancer: A Case–Control Study},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {13},
  pages = {2152},
  doi = {10.3390/cancers18132152}
}
Kostenlos starten →